NASDAQ$ADUS
Addus HomeCare Corporation · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Addus HomeCare's Q2 2022 performance reflected strong demand and improved volumes, with strategic growth execution leading to favorable results in revenue, profitability, and cash flow.
Addus HomeCare Corporation reported an 8.7% increase in net service revenues to $236.9 million for Q2 2022 compared to $217.9 million in Q2 2021. Net income was $11.3 million, with adjusted earnings per diluted share increasing to $0.91. The company's adjusted EBITDA increased by 3.1% to $25.1 million.
- Revenues grew by 8.7% reaching $236.9 million.
- Net income totaled $11.3 million, resulting in $0.70 per diluted share.
- Adjusted earnings per diluted share increased to $0.91.
- Adjusted EBITDA saw a 3.1% increase, reaching $25.1 million.
Headline financials
Revenue & EPS history
Addus · Revenue · Quarterly
$237M
Revenue by segment
Addus · $237M total across 3 segments · Q2 2022
- Personal Care$174M-1.1%73.6%
- Hospice$52.1M+41.1%22.0%
- Home Health$10.5M+123.4%4.4%
Forward guidance
Addus HomeCare anticipates continued opportunities for growth through organic expansion and strategic acquisitions, particularly in states with a strong existing presence. The company is well-capitalized and positioned to pursue acquisitions across all service lines, leveraging the increased demand for home-based care driven by the COVID-19 pandemic and reduced hospital bed availability. Investments in data analytics and technology aim to enhance caregiver capabilities and improve care coordination, effectively managing labor and industry challenges.
Tailwinds
- Opportunities for growth both organically and through acquisitions.
- Strategic focus on expansion in states with a strong existing presence.
- Robust pipeline of acquisition opportunities.
- Well-capitalized with the flexibility to pursue acquisitions in all service lines.
- Continued investments in data analytic capabilities and technologies to drive efficiencies
Headwinds
- Tight labor market for clinical staff in home health and hospice segments.
- COVID-19 pandemic and reduced availability of hospital beds
- Changes in reimbursement
- Changes in government regulations
- Increased competition for Addus HomeCare’s services
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2022
+1.2%
Avg return
Earnings day
+2.3%
Avg return
5 days after
+5.0%
Avg return
30 days after
58%
37 / 64 earnings
Positive
+23.7%
Q4 2019
Best reaction
-19.6%
Q4 2013
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.7% | -0.6% | -10.6% | |
| Q4 2025 | -9.1% | -12.0% | -17.0% | |
| Q3 2025 | -5.9% | -5.0% | -4.1% | |
| Q1 2025 | +4.1% | +6.3% | +7.5% | |
| Q4 2024 | -10.4% | -12.0% | -10.1% | |
| Q3 2024 | -1.7% | +1.0% | -2.1% | |
| Q2 2024 | +3.5% | +3.6% | +8.5% | |
| Q1 2024 | +6.5% | +11.3% | +16.8% | |
| Q4 2023 | +3.4% | +5.3% | +16.4% | |
| Q3 2023 | -3.7% | +3.3% | +7.0% | |
| Q2 2023 | +1.2% | +3.9% | -0.1% | |
| Q1 2023 | +5.8% | +0.3% | +10.3% | |
| Q4 2022 | +3.9% | +2.5% | -0.4% | |
| Q3 2022 | +3.1% | +3.8% | +4.8% | |
| Q2 2022 | +3.1% | +0.6% | -3.9% | |
| Q1 2022 | -2.3% | -4.7% | -4.2% | |
| Q4 2021 | +20.5% | +20.4% | +15.8% | |
| Q3 2021 | -0.5% | +9.1% | -8.9% | |
| Q2 2021 | +9.1% | +5.3% | +4.0% | |
| Q1 2021 | -6.6% | -8.1% | -10.0% | |
| Q4 2020 | -11.3% | -14.2% | -11.3% | |
| Q3 2020 | +11.9% | +10.3% | +4.6% | |
| Q2 2020 | +2.7% | -4.6% | -7.1% | |
| Q1 2020 | +10.2% | +2.7% | +22.5% | |
| Q4 2019 | +23.7% | +8.5% | +42.1% | |
| Q3 2019 | -0.9% | -0.1% | +8.6% | |
| Q2 2019 | +1.4% | +4.4% | -0.2% | |
| Q1 2019 | +3.6% | +3.0% | +8.8% | |
| Q4 2018 | -2.8% | -7.8% | -3.8% | |
| Q3 2018 | +6.5% | +10.8% | +16.7% | |
| Q2 2018 | -4.4% | -7.1% | -3.4% | |
| Q1 2018 | +3.1% | +1.8% | +11.9% | |
| Q4 2017 | -0.3% | +8.6% | +38.5% | |
| Q3 2017 | -1.4% | -5.8% | -7.8% | |
| Q2 2017 | -0.3% | -1.4% | -1.3% | |
| Q1 2017 | +11.3% | +9.4% | +2.6% | |
| Q4 2016 | +1.2% | +0.1% | -7.5% | |
| Q3 2016 | +17.4% | +28.7% | +32.7% | |
| Q2 2016 | +13.8% | +8.6% | +27.1% | |
| Q1 2016 | -1.1% | — | — | |
| Q4 2015 | -16.6% | — | — | |
| Q3 2015 | -12.7% | — | — | |
| Q2 2015 | +4.4% | — | — | |
| Q1 2015 | -3.4% | — | — | |
| Q4 2014 | +3.7% | — | — | |
| Q3 2014 | +7.1% | — | — | |
| Q2 2014 | +1.3% | — | — | |
| Q1 2014 | +1.8% | — | — | |
| Q4 2013 | -19.6% | — | — | |
| Q3 2013 | +4.3% | — | — | |
| Q2 2013 | +9.3% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2012 | +13.2% | — | — | |
| Q3 2012 | +10.5% | — | — | |
| Q2 2012 | +1.1% | — | — | |
| Q1 2011 | -0.0% | — | — | |
| Q1 2012 | -7.8% | — | — | |
| Q4 2011 | +6.6% | — | — | |
| Q3 2010 | -1.3% | — | — | |
| Q3 2011 | -1.3% | — | — | |
| Q2 2011 | -17.3% | — | — | |
| Q2 2010 | -17.3% | — | — | |
| Q4 2010 | +0.2% | — | — | |
| Q1 2010 | +2.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro